On Saturday, Aug. 29, Vanderbilt-Ingram Cancer Center is convening clinicians from across the Middle Tennessee area for a day of collaboration and connection at the Stem Cell Transplant and Cellular Therapy Symposium, held at the Loews Nashville Hotel at Vanderbilt Plaza from 8 a.m. to 4 p.m.
The event theme is “Emerging Applications of Novel Therapies in Hematologic Disorders and Solid Tumors.”
Adetola Kassim, MBBS, MS, Professor of Medicine in the Division of Hematology and Oncology, is the symposium chair and moderator.
Kassim said, “Advances in treatment for hematologic disorders and solid tumors continue to reshape what’s possible for patients. This symposium offers providers a forum to learn from experts, share perspectives, and apply the latest evidence to improve outcomes for their patients.”
Sessions will focus on current advances in stem cell transplantation and cancer cell therapy, and emerging applications of these novel therapies in hematologic disorders and solid tumors.
The event will begin with a welcome from Ben Ho Park, MD, PhD, Director of Vanderbilt-Ingram and Benjamin F. Byrd Jr. Professor of Oncology, and Karen Proctor, MSN, RN, NE-BC, Administrative Director of Nursing.
A limited number of tickets are available for Vanderbilt Health employees at a discounted rate. Use these codes at checkout:
- Physicians: VUMCMD
- Advanced practice providers, fellows and nurses: VUMCAPPFEL
To register and view the agenda in advance, click here. Email questions to sct_symposium@vumc.org.
